BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37467797)

  • 1. Relationship between circulating mitochondrial DNA and microRNA in patients with major depression.
    Ogata H; Higasa K; Kageyama Y; Tahara H; Shimamoto A; Takekita Y; Koshikawa Y; Nonen S; Kato T; Kinoshita T; Kato M
    J Affect Disord; 2023 Oct; 339():538-546. PubMed ID: 37467797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder.
    Lindqvist D; Wolkowitz OM; Picard M; Ohlsson L; Bersani FS; Fernström J; Westrin Å; Hough CM; Lin J; Reus VI; Epel ES; Mellon SH
    Neuropsychopharmacology; 2018 Jun; 43(7):1557-1564. PubMed ID: 29453441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways.
    Kato M; Ogata H; Tahara H; Shimamoto A; Takekita Y; Koshikawa Y; Nishida K; Nonen S; Higasa K; Kinoshita T
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant treatment increased serum miR-183 and miR-212 levels in patients with major depressive disorder.
    Lin CC; Tsai MC; Lee CT; Sun MH; Huang TL
    Psychiatry Res; 2018 Dec; 270():232-237. PubMed ID: 30269040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis.
    Funatsuki T; Ogata H; Tahara H; Shimamoto A; Takekita Y; Koshikawa Y; Nonen S; Higasa K; Kinoshita T; Kato M
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma circulating cell-free mitochondrial DNA in depressive disorders.
    Fernström J; Ohlsson L; Asp M; Lavant E; Holck A; Grudet C; Westrin Å; Lindqvist D
    PLoS One; 2021; 16(11):e0259591. PubMed ID: 34735532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis.
    Woo HI; Lim SW; Myung W; Kim DK; Lee SY
    Exp Mol Med; 2018 Aug; 50(8):1-11. PubMed ID: 30076325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
    Egami M; Imamura Y; Nabeta H; Mizoguchi Y; Yamada S
    Hum Psychopharmacol; 2013 Jan; 28(1):7-14. PubMed ID: 23124792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Maternal Circulating Cell-Free Mitochondrial DNA Is Associated With the Development of Preeclampsia.
    Cushen SC; Ricci CA; Bradshaw JL; Silzer T; Blessing A; Sun J; Zhou Z; Scroggins SM; Santillan MK; Santillan DA; Phillips NR; Goulopoulou S
    J Am Heart Assoc; 2022 Jan; 11(2):e021726. PubMed ID: 35014857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma circulating cell-free mitochondrial DNA in social anxiety disorder.
    Lindqvist D; Furmark T; Lavebratt C; Ohlsson L; Månsson KNT
    Psychoneuroendocrinology; 2023 Feb; 148():106001. PubMed ID: 36508952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Levels of Circulating Cell-Free mtDNA in the Plasma of Subjects With Late-Life Depression and Frailty: A Preliminary Study.
    Ampo E; Mendes-Silva AP; Goncalves V; Bartley JM; Kuchel GA; Diniz BS
    Am J Geriatr Psychiatry; 2022 Mar; 30(3):332-337. PubMed ID: 34412934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of caloric restriction and aerobic exercise on circulating cell-free mitochondrial DNA in patients with moderate to severe chronic kidney disease.
    Jaramillo-Morales J; Korucu B; Pike MM; Lipworth L; Stewart T; Headley SAE; Germain M; Begue G; Roshanravan B; Tuttle KR; Himmelfarb J; Robinson-Cohen C; Ikizler TA; Gamboa JL
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F68-F75. PubMed ID: 34843657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of circulating cell-free mtDNA in plasma of late life depression subjects.
    Gonçalves VF; Mendes-Silva AP; Koyama E; Vieira E; Kennedy JL; Diniz B
    J Psychiatr Res; 2021 Jul; 139():25-29. PubMed ID: 34022472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson's Disease Patients.
    Wojtkowska M; Karczewska N; Pacewicz K; Pacak A; Kopeć P; Florczak-Wyspiańska J; Popławska-Domaszewicz K; Małkiewicz T; Sokół B
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate quantitation of circulating cell-free mitochondrial DNA in plasma by droplet digital PCR.
    Ye W; Tang X; Liu C; Wen C; Li W; Lyu J
    Anal Bioanal Chem; 2017 Apr; 409(10):2727-2735. PubMed ID: 28154880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of mirtazapine as add-on to paroxetine
    Xiao L; Zhu X; Gillespie A; Feng Y; Zhou J; Chen X; Gao Y; Wang X; Ma X; Gao C; Xie Y; Pan X; Bai Y; Xu X; Wang G; Chen R
    Psychol Med; 2021 May; 51(7):1166-1174. PubMed ID: 31931894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-individual state-dependent comparison of plasma mitochondrial DNA copy number and IL-6 levels in patients with bipolar disorder.
    Kageyama Y; Deguchi Y; Kasahara T; Tani M; Kuroda K; Inoue K; Kato T
    J Affect Disord; 2022 Feb; 299():644-651. PubMed ID: 34715189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.